Selected research
Industry Research
Finasteride Tablets Industry Research Report 2026
Market perspective
The global Finasteride Tablets market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Finasteride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Finasteride Tablets is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Finasteride Tablets is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Finasteride Tablets include Accord Pharmaceuticals, Actavis, Cipla, Dr. Reddy, RelonChem, Guangdong Eashu Pharmacetical, Henan Topfond, Zhejiang CONBA Pharmaceutical and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Finasteride Tablets market in terms of revenue (US$ million) and, where applicable, sales volume (W Pcs), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Pcs) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Finasteride Tablets Market by Company
Accord Pharmaceuticals
Actavis
Cipla
Dr. Reddy
RelonChem
Guangdong Eashu Pharmacetical
Henan Topfond
Zhejiang CONBA Pharmaceutical
Merck
Shandong Renhetang Pharmaceutical
Sandoz
Teva Pharmaceuticals
Finasteride Tablets Segment by Type
1mg Tablet
5mg Tablet
Finasteride Tablets Segment by Application
Benign Prostatic Hyperplasia
Male Pattern Baldness
Others
Finasteride Tablets Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Finasteride Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Finasteride Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Finasteride Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Finasteride Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Finasteride Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Finasteride Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 1mg Tablet
- 5mg Tablet
Applications
- Benign Prostatic Hyperplasia
- Male Pattern Baldness
- Others
Companies covered
- Accord Pharmaceuticals
- Actavis
- Cipla
- Dr. Reddy
- RelonChem
- Guangdong Eashu Pharmacetical
- Henan Topfond
- Zhejiang CONBA Pharmaceutical
- Merck
- Shandong Renhetang Pharmaceutical
- Sandoz
- Teva Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Finasteride Tablets Market Size (2021-2032)
- 2.2.2 Global Finasteride Tablets Sales (2021-2032)
- 2.2.3 Global Finasteride Tablets Market Average Price (2021-2032)
- 2.3 Finasteride Tablets by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 1mg Tablet
- 2.3.3 5mg Tablet
- 2.4 Finasteride Tablets by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Benign Prostatic Hyperplasia
- 2.4.3 Male Pattern Baldness
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Finasteride Tablets Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Finasteride Tablets Sales (W Pcs) of Manufacturers (2021-2026)
- 3.3 Global Finasteride Tablets Revenue of Manufacturers (2021-2026)
- 3.4 Global Finasteride Tablets Average Price by Manufacturers (2021-2026)
- 3.5 Global Finasteride Tablets Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Finasteride Tablets, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Finasteride Tablets, Product Type & Application
- 3.8 Global Manufacturers of Finasteride Tablets, Established Date
- 3.9 Global Finasteride Tablets Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Accord Pharmaceuticals
- 4.1.1 Accord Pharmaceuticals Company Information
- 4.1.2 Accord Pharmaceuticals Business Overview
- 4.1.3 Accord Pharmaceuticals Finasteride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Accord Pharmaceuticals Finasteride Tablets Product Portfolio
- 4.1.5 Accord Pharmaceuticals Recent Developments
- 4.2 Actavis
- 4.2.1 Actavis Company Information
- 4.2.2 Actavis Business Overview
- 4.2.3 Actavis Finasteride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Actavis Finasteride Tablets Product Portfolio
- 4.2.5 Actavis Recent Developments
- 4.3 Cipla
- 4.3.1 Cipla Company Information
- 4.3.2 Cipla Business Overview
- 4.3.3 Cipla Finasteride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Cipla Finasteride Tablets Product Portfolio
- 4.3.5 Cipla Recent Developments
- 4.4 Dr. Reddy
- 4.4.1 Dr. Reddy Company Information
- 4.4.2 Dr. Reddy Business Overview
- 4.4.3 Dr. Reddy Finasteride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Dr. Reddy Finasteride Tablets Product Portfolio
- 4.4.5 Dr. Reddy Recent Developments
- 4.5 RelonChem
- 4.5.1 RelonChem Company Information
- 4.5.2 RelonChem Business Overview
- 4.5.3 RelonChem Finasteride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 RelonChem Finasteride Tablets Product Portfolio
- 4.5.5 RelonChem Recent Developments
- 4.6 Guangdong Eashu Pharmacetical
- 4.6.1 Guangdong Eashu Pharmacetical Company Information
- 4.6.2 Guangdong Eashu Pharmacetical Business Overview
- 4.6.3 Guangdong Eashu Pharmacetical Finasteride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Guangdong Eashu Pharmacetical Finasteride Tablets Product Portfolio
- 4.6.5 Guangdong Eashu Pharmacetical Recent Developments
- 4.7 Henan Topfond
- 4.7.1 Henan Topfond Company Information
- 4.7.2 Henan Topfond Business Overview
- 4.7.3 Henan Topfond Finasteride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Henan Topfond Finasteride Tablets Product Portfolio
- 4.7.5 Henan Topfond Recent Developments
- 4.8 Zhejiang CONBA Pharmaceutical
- 4.8.1 Zhejiang CONBA Pharmaceutical Company Information
- 4.8.2 Zhejiang CONBA Pharmaceutical Business Overview
- 4.8.3 Zhejiang CONBA Pharmaceutical Finasteride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Zhejiang CONBA Pharmaceutical Finasteride Tablets Product Portfolio
- 4.8.5 Zhejiang CONBA Pharmaceutical Recent Developments
- 4.9 Merck
- 4.9.1 Merck Company Information
- 4.9.2 Merck Business Overview
- 4.9.3 Merck Finasteride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Merck Finasteride Tablets Product Portfolio
- 4.9.5 Merck Recent Developments
- 4.10 Shandong Renhetang Pharmaceutical
- 4.10.1 Shandong Renhetang Pharmaceutical Company Information
- 4.10.2 Shandong Renhetang Pharmaceutical Business Overview
- 4.10.3 Shandong Renhetang Pharmaceutical Finasteride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Shandong Renhetang Pharmaceutical Finasteride Tablets Product Portfolio
- 4.10.5 Shandong Renhetang Pharmaceutical Recent Developments
- 4.11 Sandoz
- 4.11.1 Sandoz Company Information
- 4.11.2 Sandoz Business Overview
- 4.11.3 Sandoz Finasteride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Sandoz Finasteride Tablets Product Portfolio
- 4.11.5 Sandoz Recent Developments
- 4.12 Teva Pharmaceuticals
- 4.12.1 Teva Pharmaceuticals Company Information
- 4.12.2 Teva Pharmaceuticals Business Overview
- 4.12.3 Teva Pharmaceuticals Finasteride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Teva Pharmaceuticals Finasteride Tablets Product Portfolio
- 4.12.5 Teva Pharmaceuticals Recent Developments
5 Global Finasteride Tablets Market Scenario by Region
- 5.1 Global Finasteride Tablets Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Finasteride Tablets Sales by Region: 2021-2032
- 5.2.1 Global Finasteride Tablets Sales by Region: 2021-2026
- 5.2.2 Global Finasteride Tablets Sales by Region: 2027-2032
- 5.3 Global Finasteride Tablets Revenue by Region: 2021-2032
- 5.3.1 Global Finasteride Tablets Revenue by Region: 2021-2026
- 5.3.2 Global Finasteride Tablets Revenue by Region: 2027-2032
- 5.4 North America Finasteride Tablets Market Facts & Figures by Country
- 5.4.1 North America Finasteride Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Finasteride Tablets Sales by Country (2021-2032)
- 5.4.3 North America Finasteride Tablets Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Finasteride Tablets Market Facts & Figures by Country
- 5.5.1 Europe Finasteride Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Finasteride Tablets Sales by Country (2021-2032)
- 5.5.3 Europe Finasteride Tablets Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Finasteride Tablets Market Facts & Figures by Country
- 5.6.1 Asia Pacific Finasteride Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Finasteride Tablets Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Finasteride Tablets Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Finasteride Tablets Market Facts & Figures by Country
- 5.7.1 South America Finasteride Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Finasteride Tablets Sales by Country (2021-2032)
- 5.7.3 South America Finasteride Tablets Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Finasteride Tablets Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Finasteride Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Finasteride Tablets Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Finasteride Tablets Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Finasteride Tablets Sales by Type (2021-2032)
- 6.1.1 Global Finasteride Tablets Sales by Type (2021-2032) & (W Pcs)
- 6.1.2 Global Finasteride Tablets Sales Market Share by Type (2021-2032)
- 6.2 Global Finasteride Tablets Revenue by Type (2021-2032)
- 6.2.1 Global Finasteride Tablets Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Finasteride Tablets Revenue Market Share by Type (2021-2032)
- 6.3 Global Finasteride Tablets Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Finasteride Tablets Sales by Application (2021-2032)
- 7.1.1 Global Finasteride Tablets Sales by Application (2021-2032) & (W Pcs)
- 7.1.2 Global Finasteride Tablets Sales Market Share by Application (2021-2032)
- 7.2 Global Finasteride Tablets Revenue by Application (2021-2032)
- 7.2.1 Global Finasteride Tablets Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Finasteride Tablets Revenue Market Share by Application (2021-2032)
- 7.3 Global Finasteride Tablets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Finasteride Tablets Value Chain Analysis
- 8.1.1 Finasteride Tablets Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Finasteride Tablets Production Mode & Process
- 8.2 Finasteride Tablets Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Finasteride Tablets Distributors
- 8.2.3 Finasteride Tablets Customers
9 Global Finasteride Tablets Analyzing Market Dynamics
- 9.1 Finasteride Tablets Industry Trends
- 9.2 Finasteride Tablets Industry Drivers
- 9.3 Finasteride Tablets Industry Opportunities and Challenges
- 9.4 Finasteride Tablets Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst